# FDA WARNING_LETTER - LifeSilver - October 31, 2014

Source: https://www.keypedia.com/records/warning_letter/lifesilver/966b2619-7f39-457b-a49b-7e6159784c4d

> FDA WARNING_LETTER for LifeSilver on October 31, 2014. Product: Food. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: LifeSilver
- Inspection Date: 2014-10-31
- Product Type: Food
- Office Name: Center for Food Safety and Applied Nutrition
- Summary: In October 2014, the FDA and FTC reviewed LifeSilver's website (lifesilver.com) and Facebook page, identifying violations related to their products: "ASAP Solution," "Patis 30 Fortified Silver Solution," "ASAP Ultimate Skin & Body Care Gel," "Combo Wellness Pack," and "Combo Gel Pack."

The agencies determined that therapeutic claims on the website and Facebook, such as "EBOLA AND NANO-SILVER VIRAL IMMUNIZATION" and claims about preventing/treating viral infections (including Ebola), cause these products to be unapproved new drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)]. These products are not generally recognized as safe and effective for their claimed uses, making them "new drugs" under section 201(p) of the Act [21 U.S.C. § 321(p)], requiring prior FDA approval.

Furthermore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] because they are offered for conditions not amenable to self-diagnosis and treatment, meaning adequate directions for layperson use cannot be provided. The letter also notes that while

## Related Officers

- [Associate Director](https://www.keypedia.com/people/mary-k-engle/9426dfba-028c-4d3a-bb62-7bdea653e6bc)
- [Director](https://www.keypedia.com/people/william-a-correll/f9e634a2-8e56-4c9b-984c-304f0c7db122)

Company: https://www.keypedia.com/companies/lifesilver/76cd8ff7-2981-47b5-82f6-8261f09364d7

Office: https://www.keypedia.com/offices/center-for-food-safety-and-applied-nutrition/e04dc4e5-ee4f-4b0d-be8c-1139531ddab2